期刊
ACS CENTRAL SCIENCE
卷 8, 期 9, 页码 1336-1349出版社
AMER CHEMICAL SOC
DOI: 10.1021/acscentsci.2c00741
关键词
-
资金
- Key Fields of Biomedicine and Health Foundation of Colleges and Universities in Guangdong Province [2022ZDZX2017]
- Guangdong Basic and Applied Basic Research Foundation [2019B1515120043, 2022A1515012154]
- National Natural Science Foundation of China [82104354]
- Science and Technology Development Fund, Macau SAR [0016/2021/A]
Nanodecoys designed using rabies virus polypeptide effectively protect dopaminergic neurons in PD mice, enhance blood-brain barrier crossing, and show promising potential in treating neurodegenerative diseases.
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the gradual loss of dopaminergic neurons in the substantia nigra and the accumulation of alpha-synuclein aggregates called Lewy bodies. Here, nanodecoys were designed from a rabies virus polypeptide with a 29 amino acid (RVG29)-modified red blood cell membrane (RBCm) to encapsulate curcumin nanocrystals (Cur-NCs), which could effectively protect dopaminergic neurons. The RVG29-RBCm/Cur-NCs nanodecoys effectively escaped from retic-uloendothelial system (RES) uptake, enabled prolonged blood circulation, and enhanced blood-brain barrier (BBB) crossing after systemic administration. Cur-NCs loaded inside the nanodecoys exhibited the recovery of dopamine levels, inhibition of alpha-synuclein aggregation, and reversal of mitochondrial dysfunction in PD mice. These findings indicate the promising potential of biomimetic nanodecoys in treating PD and other neurodegenerative diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据